Montpellier: MedVallée startups attract investors

While biotech company CILCare, which specializes in hearing loss treatments, raised €40 million in December 2024, five other companies that have been or are still assisted by Montpellier BIC have just secured significant funding. Here is a closer look at these players in global health innovation in our area.

The 2nd MedVallée Conference was held at the Corum in October 2024 - © Frédéric Damerdji

Five young companies assisted by Montpellier Métropole and based locally recently raised significant funds to develop their activities.

Three are based in Montpellier: MABQI (prostate cancer specialist) at Biopôle Euromédecine, Terratis (mosquito control) at Parc 2000, and MB Therapeutics (3D printing of specialized medicinal products) at the Ateliers Relais du Millénaire interim workshops.

MedinCell (pharmaceuticals) is based in Jacou and La Picorée (clinical nutrition specialist), at the Cap Alpha incubator in Clapiers.

In order to meet their specific technical needs in terms of business facilities, these companies benefited from the Montpellier Métropole business establishment support program.

Montpellier: MedVallée startups attract investors

Address